Metabolic syndrome and schizophrenia

by Dr Arijit Bose and Dr Sepehr Hafizi


Last updated: July 2017


The World Health Organization (WHO) has recognised metabolic syndrome as a global epidemic (Potenza & Mechanick, 2009). Its causes are not fully understood but its effects can be severe, such as type 2 diabetes mellitus and cardiovascular disease.


Contributory factors include diet, smoking, genetics, lack of exercise and excess alcohol. It is a common comorbidity in people with schizophrenia and, in addition, some antipsychotic agents are implicated in worsening the risks.

Appropriate intervention by clinicians can reduce the risk of mortality and morbidity. This module will offer a framework to help with the diagnosis of metabolic syndrome and will advise on appropriate treatment paths for patients at risk.

This module will answer the following questions:

  • What is metabolic syndrome and how is it diagnosed?


  • What is the link between schizophrenia and metabolic syndrome?


  • What is the relationship between antipsychotic agents and metabolic syndrome?


  • Why is it difficult to manage patients with both schizophrenia and metabolic syndrome?


Start the module


If you like this module, you may also be interested in:


Alcohol-related brain damage by Professor Kenneth Wilson et al


First-episode psychosis: Part 1 and Part 2 by Dr Andrew Thompson et al


Social functioning in schizophrenia by Dr K. Thyarappa Praveen and Dr Rob Macpherson




Related Advances articles


Download take-home notes to print and annotateDownload take-home notes to print and annotate


© 2019 Royal College of Psychiatrists